Stock Events

Stock Events

Myomo 

$1.3787
76
-$0.04-2.91% Today

Statistics

Day High
1.4797
Day Low
1.33
52W High
2.68
52W Low
0.605
Volume
3,984,010
Avg. Volume
-
Mkt Cap
52.99M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

11AugExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
-0.11
-0.08
-0.04
-0.01
Expected EPS
-0.098
Actual EPS
N/A

Financials

-19%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
65.1MRevenue
-12.37MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MYO. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Ekso Bionics
EKSO
Mkt Cap42.05M
Ekso Bionics designs and manufactures powered exoskeletons which can be used for rehabilitation and mobility, directly competing with Myomo's mobility enhancement devices.
Resmed
RMD
Mkt Cap28.25B
ResMed is known for its products in the sleep and respiratory markets but also offers devices that can improve quality of life, indirectly competing with Myomo's focus on enhancing mobility.
Smith & Nephew
SNN
Mkt Cap12.95B
Smith & Nephew specializes in orthopedics, including robotics and digital solutions for surgery, which can indirectly compete with Myomo's orthotic devices by offering alternative treatments and rehabilitation methods.
Zimmer Biomet
ZBH
Mkt Cap17.13B
Zimmer Biomet Holdings, Inc. focuses on musculoskeletal healthcare, including products for joint reconstruction which can indirectly compete with Myomo's solutions for mobility and rehabilitation.
Medtronic
MDT
Mkt Cap102.97B
Medtronic plc offers a wide range of medical devices and therapies, including those for spinal and musculoskeletal conditions, indirectly competing with Myomo's assistive technologies.
Stryker
SYK
Mkt Cap119.69B
Stryker Corporation specializes in medical and surgical equipment, including neurotechnology and spine products, which can indirectly compete with Myomo's focus on enhancing mobility through technology.
Globus Medical
GMED
Mkt Cap10.91B
Globus Medical, Inc. focuses on musculoskeletal solutions, including innovative spine and orthopedic devices, indirectly competing with Myomo by offering alternative treatments for mobility impairments.

About

Myomo, Inc. is a medical technology company specializing in wearable robotics. The company engineers and manufactures advanced myoelectric orthoses, primarily for individuals in the United States who experience neuromuscular impairments. Its flagship product, MyoPro, is an upper-limb brace that utilizes muscle signals to assist patients with weak or paralyzed arms, thereby enhancing their ability to perform daily activities. These devices aim to restore function for both adult and adolescent patients suffering from various neurological conditions, including stroke, spinal cord injury, traumatic brain injury, and brachial plexus injuries. Myomo distributes its innovative solutions through a network that includes orthotics and prosthetics providers, rehabilitation hospitals, the Veterans Health Administration, and additional distributors. Established in 2004, Myomo, Inc. maintains its corporate headquarters in Boston, Massachusetts.
Show more...
CEO
Mr. Paul R. Gudonis
Employees
184
Country
United States
ISIN
US62857J2015

Listings

MU
DE
0M61.MU
STU
DE
0M61.STU
F
DE
0M61.F
XASE
US
MYO

0 Comments

Share your thoughts

FAQ

What is Myomo stock price today?▼
The current price of MYO is $1.38 USD — it has decreased by -2.91% in the past 24 hours. Watch Myomo stock price performance more closely on the chart.
What is Myomo stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Myomo stocks are traded under the ticker MYO.
Is Myomo stock price growing?▼
MYO stock has risen by +0% compared to the previous week, the month change is a +62.33% rise, over the last year Myomo has showed a -49.82% decrease.
What is Myomo market cap?▼
Today Myomo has the market capitalization of 52.99M
When is the next Myomo earnings date?▼
Myomo is going to release the next earnings report on August 11, 2026.
What were Myomo earnings last quarter?▼
MYO earnings for the last quarter are -0.07 USD per share, whereas the estimation was -0.11 USD resulting in a +38.6% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Myomo revenue for the last year?▼
Myomo revenue for the last year amounts to 65.1M USD.
What is Myomo net income for the last year?▼
MYO net income for the last year is -12.37M USD.
How many employees does Myomo have?▼
As of June 18, 2026, the company has 184 employees.
In which sector is Myomo located?▼
Myomo operates in the Health & Wellness sector.
When did Myomo complete a stock split?▼
The last stock split for Myomo was on January 31, 2020 with a ratio of 1:30.
Where is Myomo headquartered?▼
Myomo is headquartered in Burlington, United States.